Episode

Biobanks & neurodegenerative diseases | Karel Kalecký

Podcast
The Metabolomist podcast
Published
Aug 1, 2023
Duration seconds
3263
Processing state
not_requested
Canonical source
https://the-metabolomist.podigee.io/205-karel-kalecky
Audio
https://audio.podigee-cdn.net/1171287-m-49406d749f34a11ee934e1af29920776.mp3?source=feed
JSON
/v1/public/podcasts/the-metabolomist-podcast-5381703/episodes/biobanks-neurodegenerative-diseases-karel-kaleck
Markdown
/podcast/the-metabolomist-podcast-5381703/biobanks-neurodegenerative-diseases-karel-kaleck.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-metabolomist-podcast-5381703/episodes/biobanks-neurodegenerative-diseases-karel-kaleck/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-metabolomist-podcast-5381703/biobanks-neurodegenerative-diseases-karel-kaleck.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode, Alice Limonciel and Karel Kalecký discuss what to look out for when planning a metabolomics experiment with brain tissue samples from biobanks, what characterizes Parkinson’s and Alzheimer’s disease at the metabolic level, and his experience navigating biological interpretation as a computer scientist turned metabolomist.